Baseline Tumour Size as a Prognostic Factor for Radioiodine-refractory Differentiated Thyroid Cancer Treated With Lenvatinib

Fukuda, N; Toda, K; Ohmoto, A; Wang, XF; Hayashi, N; Urasaki, T; Sato, Y; Nakano, K; Ono, M; Tomomatsu, J; Mitani, H; Takahashi, S

Fukuda, N (corresponding author), Japanese Fdn Canc Res, Canc Inst Hosp, Koto Ku, 3-8-31 Ariake, Tokyo 1358550, Japan.

ANTICANCER RESEARCH, 2021; 41 (3): 1683

Abstract

Background/Aim: Lenvatinib is standard therapy for radioiodine-refractory differentiated thyroid cancer (RR-DTC), although the optimal timing for star......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索